These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
324 related items for PubMed ID: 29396065
1. Variable response of CNS hemangioblastomas to Pazopanib in a single patient with von Hippel-Lindau disease: Case report. Taylor DG, Ilyas A, Mehta GU, Chen CJ, Schiff D, Oldfield EH, Asthagiri AR. J Clin Neurosci; 2018 Apr; 50():154-156. PubMed ID: 29396065 [Abstract] [Full Text] [Related]
2. Recurrent multiple CNS hemangioblastomas with VHL disease treated with pazopanib: a case report and literature review. Migliorini D, Haller S, Merkler D, Pugliesi-Rinaldi A, Koka A, Schaller K, Leemann B, Dietrich PY. CNS Oncol; 2015 Apr; 4(6):387-92. PubMed ID: 26497655 [Abstract] [Full Text] [Related]
3. Pazopanib therapy for cerebellar hemangioblastomas in von Hippel-Lindau disease: case report. Kim BY, Jonasch E, McCutcheon IE. Target Oncol; 2012 Jun; 7(2):145-9. PubMed ID: 22374327 [Abstract] [Full Text] [Related]
4. The outcome of central nervous system hemangioblastomas in Von Hippel-Lindau (VHL) disease treated with belzutifan: a single-institution retrospective experience. Zamarud A, Marianayagam NJ, Park DJ, Yener U, Yoo KH, Meola A, Chang SD. J Neurooncol; 2023 Nov; 165(2):373-379. PubMed ID: 37955759 [Abstract] [Full Text] [Related]
7. [Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)]. Richard S, Giraud S, Beroud C, Caron J, Penfornis F, Baudin E, Niccoli-Sire P, Murat A, Schlumberger M, Plouin PF, Conte-Devolx B. Ann Endocrinol (Paris); 1998 Nov; 59(6):452-8. PubMed ID: 10189987 [Abstract] [Full Text] [Related]
9. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene. Muscarella LA, Bisceglia M, Galliani CA, Zidar N, Ben-Dor DJ, Pasquinelli G, la Torre A, Sparaneo A, Fanburg-Smith JC, Lamovec J, Michal M, Bacchi CE. Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223 [Abstract] [Full Text] [Related]
12. Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, van Leeuwaarde RS, Ahmad S, van Nesselrooij B, Zandee W, Giles RH. ; 1993 Aug. PubMed ID: 20301636 [Abstract] [Full Text] [Related]
13. Screening and surveillance recommendations for central nervous system hemangioblastomas in pediatric patients with Von Hippel-Lindau disease. Knoblauch AL, Blaß BI, Steiert C, Neidert N, Puzik A, Neumann-Haefelin E, Ganner A, Kotsis F, Schäfer T, Neumann HPH, Elsheikh S, Beck J, Klingler JH. J Neurooncol; 2024 Jul; 168(3):537-545. PubMed ID: 38647646 [Abstract] [Full Text] [Related]
15. A Case of von Hippel-Lindau Disease with Colorectal Adenocarcinoma, Renal Cell Carcinoma and Hemangioblastomas. Heo SJ, Lee CK, Hahn KY, Kim G, Hur H, Choi SH, Han KS, Cho A, Jung M. Cancer Res Treat; 2016 Jan; 48(1):409-14. PubMed ID: 25715769 [Abstract] [Full Text] [Related]